Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,510,772 | 4,604,979 | 4,247,147 | 8,116,808 | 14,715,520 |
| Marketable Securities | 5,114,308 | 5,373,094 | 4,441,484 | 215,946 | 4,274,975 |
| Receivables | 8,660,310 | 9,224,800 | 9,533,113 | 8,625,285 | 11,803,820 |
| Inventories | 6,505,254 | 6,365,087 | 5,487,370 | 5,855,652 | 8,054,825 |
| Other current assets | 163,996 | 121,220 | 140,156 | 45,219,339 | 46,960 |
| TOTAL | $23,954,640 | $25,689,180 | $23,849,270 | $68,033,030 | $38,896,100 |
| Non-Current Assets | |||||
| PPE Net | 10,639,220 | 11,049,230 | 10,483,600 | 10,675,520 | 13,369,700 |
| Investments And Advances | 1,627,832 | 1,906,063 | 1,933,948 | 2,183,315 | 2,354,859 |
| Intangibles | 25,531,454 | 26,425,127 | 26,834,991 | 21,691,273 | 55,245,930 |
| Other Non-Current Assets | 9,429,274 | 9,324,990 | 7,934,841 | 9,212,852 | 10,478,101 |
| TOTAL | $47,227,780 | $48,705,410 | $47,187,380 | $43,762,960 | $81,448,590 |
| Total Assets | $71,182,420 | $74,394,590 | $71,036,650 | $111,796,000 | $120,344,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,176,263 | 4,888,229 | 3,289,595 | 4,177,048 | 5,504,063 |
| Accounts payable and accrued liabilities | 17,332,770 | 20,115,710 | 18,980,250 | 18,588,930 | 23,584,820 |
| Accrued Expenses | 515,075 | 582,580 | 151,936 | 370,373 | 1,050,629 |
| Other current liabilities | 2,117,396 | 2,627,176 | 2,256,665 | 24,365,490 | 2,436,709 |
| TOTAL | $25,141,500 | $28,213,690 | $24,678,440 | $47,501,840 | $32,576,220 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,219,130 | 21,070,590 | 22,757,450 | 23,583,310 | 39,215,450 |
| Other Non-Current Liabilities | 11,556,391 | 12,149,084 | 12,861,574 | 11,927,257 | 12,773,931 |
| TOTAL | $32,299,100 | $33,693,160 | $36,092,500 | $35,869,640 | $57,400,860 |
| Total Liabilities | $57,440,600 | $61,906,840 | $60,770,950 | $83,371,480 | $89,977,090 |
| Shareholders' Equity | |||||
| Common Shares | 1,637,550 | 1,666,104 | 1,586,497 | 1,691,158 | 1,807,405 |
| Retained earnings | 6,869,694 | 5,396,595 | 3,052,858 | 12,334,030 | 12,930,930 |
| Other shareholders' equity | 1,044,731 | 1,170,105 | 1,574,723 | 10,081,667 | 11,018,860 |
| TOTAL | $13,741,820 | $12,487,740 | $10,265,710 | $28,424,520 | $30,367,620 |
| Total Liabilities And Equity | $71,182,420 | $74,394,580 | $71,036,660 | $111,796,000 | $120,344,710 |